BullFrog AI (BFRG) Holdings announces the coming launch of a new scenario-based decision engine for pharmaceutical portfolio strategy and clinical trial design. Key capabilities include: Compares drug programs, indications, and trial designs without forcing arbitrary numerical scores; Tests portfolio decisions against multiple explicit scenarios; Identifies options that perform well across strategic futures; Preserves portfolio diversity while surfacing clear leaders to balance concentration with risk mitigation
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRG:
